Prebiotics and Microbiota Composition and Functionality in Rural Burkinabe Infants
Effect of Supplementation With LNS Fortified With a Mixture of FOS and Inulin on Gut Microbiota Diversity and Functionality and Its Repercussion on Growth and Morbidity During Infancy in Rural Burkina Faso
1 other identifier
interventional
153
1 country
1
Brief Summary
The purpose of this study is to assess the effect of a mixture of prebiotics included in a food supplement on microbiota diversity and functionality, and to explore its subsequent effects on linear growth velocity and morbidity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2016
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedFirst Posted
Study publicly available on registry
March 23, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedJune 11, 2020
June 1, 2020
2.1 years
February 1, 2016
June 8, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Fecal microbiota range-weighted richness
Composition of fecal microbiota will be determined by Illumina sequencing from which range-weighted richness will be calculated
6 months
Mean concentration of short-chain fatty acids in stool
Concentration of short-chain fatty acids (acetate, butyrate and propionate) will be measured by Gas Chromatography
6 months
Secondary Outcomes (11)
Frequency of digestive intolerance symptoms (flatulence, abdominal pain, regurgitation, vomiting, or diarrhea)
once every week during the first month of supplementation
Stool consistency
Once every week during the first month of supplementation
Stool frequency per day
6 months
Mean stool pH
once every week during the first month of supplementation
Calprotectin concentration in stool
at inclusion, 3 months and 6months after inclusion
- +6 more secondary outcomes
Study Arms (3)
Fortified lipid based nutrient supplement
EXPERIMENTALlipid based nutrient supplement (Nutributter) fortified with fructo-oligosaccharides and inulin
lipid based nutrient supplement
ACTIVE COMPARATORlipid based nutrient supplement (Nutributter)
non intervention group
NO INTERVENTIONThis group will not be supplemented
Interventions
6 months intervention: participant will take a daily dose of 20g supplement. The product contains 3 g of a mixture (1:1) of inulin and fructan-oligosaccharide
Dietary Supplement: lipid based nutrient supplement (Nutributter) 6 months intervention: participant will take a daily dose of 20g supplement.
Eligibility Criteria
You may qualify if:
- month old infants
- Weight for height and height for age z-score above -2
- Permanent resident of the area and not intending to move for the next 6 months for more than a week
- No chronic antibiotic treatment
- Exempt of any current serious illness
- Still breastfed.
You may not qualify if:
- Moderate or severe malnutrition (weight for height or height for age z-score below -2)
- non-permanent residence in the study area,
- the presence of any congenital anomalies in the child or mental/physical disease of the mother that can interfere with child feeding
- a chronic antibiotic treatment i.e. more than 6 weeks treatment at the time of enrolment
- a history of allergy to a constituent of the supplement
- a serious current illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
- Institut de Recherche en Sciences de la Sante, Burkina Fasocollaborator
- Nutrisetcollaborator
Study Sites (1)
IRSS/DRO
Bobo-Dioulasso, Houet, 01 BP 545, Burkina Faso
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2016
First Posted
March 23, 2016
Study Start
March 1, 2016
Primary Completion
April 24, 2018
Study Completion
November 1, 2019
Last Updated
June 11, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will share
Upon publication of the main findings, data will be shared on a public repository and made publicly available on request as per recently published guidance and regulations (BMJ 2016;352:i255)